HH BIOTECHNOLOGY HOLDINGS CO: key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2015)
- $8.0M
- Net Income/Loss (FY2015)
- $2.4M
- Total Assets (FY2015)
- $46.5M
- Total Equity (FY2015)
- $28.4M
- Cash Flows from Operating Activities (FY2015)
- $3.6M
Source: HH BIOTECHNOLOGY HOLDINGS CO 10-K filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
